Technical Analysis for VNRX - VolitionRX Limited

Grade Last Price % Change Price Change
F 3.3 -0.30% -0.01
VNRX closed down 0.3 percent on Thursday, April 15, 2021, on 45 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: May 5
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical VNRX trend table...

Date Alert Name Type % Chg
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness -0.30%
Down 3 Days in a Row Weakness -0.30%
Down 4 Days in a Row Weakness -0.30%
Oversold Stochastic Weakness -0.30%
Narrow Range Bar Range Contraction -4.07%
NR7 Range Contraction -4.07%
Older End-of-Day Signals for VNRX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 1% 1 day ago
Up 1% 2 days ago
Down 2 % 2 days ago
Down 1% 2 days ago
Fell Below Previous Day's Low 2 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

VolitionRX Limited Description

VolitionRX Limited, a development stage life sciences company, focuses on developing cancer detection blood tests for detecting and diagnosing cancer and other diseases. It develops two blood tests in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer and nucleosomes containing specific histone variants. The company also develops nine blood tests in the NuQ-M family to detect cancer by detecting nucleosomes containing modified histones, the proteins that package, and order DNA into nucleosomes; and five blood tests in the NuQ-A family to detect cancer by detecting nucleosome-protein adducts, as well as offers research kits. It develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help appropriate therapy; NuQ Endo endometriosis test; and NuQ clinical diagnostic products. VolitionRX Limited is based in Singapore.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Biology Diseases Disease Molecular Biology Genomics Diagnostic Products Blood Test Blood Tests Nucleotides Endometriosis Epigenetics

Is VNRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.67
52 Week Low 2.78
Average Volume 471,017
200-Day Moving Average 3.70
50-Day Moving Average 4.15
20-Day Moving Average 3.54
10-Day Moving Average 3.53
Average True Range 0.26
ADX 15.11
+DI 14.15
-DI 22.39
Chandelier Exit (Long, 3 ATRs ) 3.52
Chandelier Exit (Short, 3 ATRs ) 4.01
Upper Bollinger Band 3.85
Lower Bollinger Band 3.24
Percent B (%b) 0.1
BandWidth 17.18
MACD Line -0.16
MACD Signal Line -0.17
MACD Histogram 0.0013
Fundamentals Value
Market Cap 159.05 Million
Num Shares 48.2 Million
EPS -0.48
Price-to-Earnings (P/E) Ratio -6.88
Price-to-Sales 23023.98
Price-to-Book 8.50
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.54
Resistance 3 (R3) 3.55 3.48 3.50
Resistance 2 (R2) 3.48 3.42 3.48 3.49
Resistance 1 (R1) 3.39 3.38 3.36 3.38 3.47
Pivot Point 3.32 3.32 3.30 3.32 3.32
Support 1 (S1) 3.23 3.26 3.20 3.22 3.13
Support 2 (S2) 3.16 3.22 3.16 3.11
Support 3 (S3) 3.07 3.16 3.10
Support 4 (S4) 3.06